Brain Metastatic Lung Cancer Patients: A Multitarget Therapeutic-Supportive Strategy with Anti-STAT3 Silibinin
Our study is the first collection of a large number of lung cancer patients with brain metastasis taking silibinin, which is very well tolerated and allows patients to maintain a good QoL.
Authors
- Elena Roca (ORCID: https://orcid.org/0000-0002-2314-7000)
- Antonio Santo (ORCID: https://orcid.org/0009-0003-7099-7862)
- A. Cucinella (ORCID: https://orcid.org/0000-0003-1277-3986)
- Giorgio Madonia (ORCID: https://orcid.org/0000-0003-4648-7646)
- Elisa Roca (ORCID: https://orcid.org/0000-0001-7625-7708)
- Giovanni Centonze (ORCID: https://orcid.org/0000-0003-2864-7941)
- Fiorella Lombardo
- Licia Martinelli
- Maria Elisa Damiani
Institutions
- Casa di Cura Villa Garda (IT)
- Azienda Sanitaria Locale CN2 (IT)
- Fondazione Poliambulanza Istituto Ospedaliero (IT)
Publication Details
- Journal
- NeuroSci
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3390/neurosci6040131
- Primary Topic
- Silymarin and Mushroom Poisoning
- Type
- article
- Field-Weighted Citation Impact
- 0.00